[2P] 69 Alzheimer's Disease and Dementia

[2P-316] In vitro disease modeling of FTLD using patient-derived iPSCs identified potential therapeutic agent and mechanism.

*Hiroshi Kokubu¹, Satoru Hayashi¹, Komei Fukushima¹, Hideyuki Okano^1,2 (1. K Pharma Inc., 2. Department of Physiology, Keio University School of Medicine)

Keywords:frontotemporal lobar degeneration, iPSCs, Drug screening, dementia